94
Views
0
CrossRef citations to date
0
Altmetric
Articles

Kinetic modelling of colour and turbidity formation in aqueous solutions of sulphamethoxazole degraded by UV/H2O2

ORCID Icon, ORCID Icon & ORCID Icon
Pages 349-359 | Received 14 Jun 2022, Accepted 28 Jul 2022, Published online: 18 Aug 2022

References

  • Dieleman JL, Squires E, Bui AL, et al. Factors associated with increases in US health care spending, 1996-2013. JAMA. 2017;318(17):1668–1678. doi:10.1001/jama.2017.15927.
  • Tev S, Morgan EN, Cu CN, et al. Population aging and the determinants of healthcare expenditures: the case of hospital, medical and pharmaceutical care in British Columbia, 1996 to 2006. Healthcare Policy. 2011;7(1):68–79.
  • der Beek TA, Weber FA, Bergmann A, et al. Pharmaceuticals in the environment-global occurrences and perspectives. Environ Toxicol Chem. 2015;35(4):823–835. doi:10.1002/etc.3339.
  • Halling-Sorensen B, Nielsen SN, Lanzky PF, et al. Occurrence, fate and effects of pharmaceutical substances in the environment-A review. Chemosphere. 1998;36(2):357–394. doi:10.1016/S0045-6535(97)00354-8.
  • Kümmerer K. Pharmaceuticals in the environment. Annu Rev. 2010;35:57–75. doi:10.1146/annurev-environ-052809-161223.
  • Nghiem LD, Hawkes S. Effects of membrane fouling on the nanofiltration of pharmaceutically active compounds (PhACs): mechanisms and role of membrane pore size. Sep Purif Technol. 2007;57(1):176–184. doi:10.1016/j.seppur.2007.04.002.
  • Hirsch R, Ternes T, Haberer K, et al. Occurrence of antibiotics in the aquatic environment. Sci Total Environ. 1999;225(1–2):109–118. doi:10.1016/S0048-9697(98)00337-4.
  • Sisson ME, Rieder MJ, Bird IA, et al. Suppression of pokeweed mitogen-driven human IgM and IgG responses by the hydroxylamine of sulfamethoxazole. Int J Immunopharmacol. 1997;19(5):299–304. doi:10.1016/S0192-0561(97)00027-1.
  • Gao S, Zhao Z, Xu Y, et al. Oxidation of sulfamethoxazole (SMX) by chlorine, ozone and permanganate—A comparative study. J Hazard Mater. 2014;274:258–269. doi:10.1016/j.jhazmat.2014.04.024.
  • Alharbi SK, Kang J, Nghiem LD, et al. Photolysis and UV/H2O2 of diclofenac, sulfamethoxazole, carbamazepine, and trimethoprim: identification of their major degradation products by ESI-LC-MS and assessment of the toxicity of reaction mixtures. Process Saf Environ Prot. 2017;112(Part b):222–234. doi:10.1016/j.psep.2017.07.015.
  • Epold I, Dulova N, Veressinina Y, et al. Application of ozonation, UV photolysis, Fenton treatment and other related processes for degradation of ibuprofen and sulfamethoxazole in different aqueous matrices. J Adv Oxid Technol. 2012;15(2). doi:10.1515/jaots-2012-0215.
  • Wang J, Wang S. Removal of pharmaceuticals and personal care products (PPCPs) from wastewater: A review. J Environ Manage. 2016;182:620–640. doi:10.1016/j.jenvman.2016.07.049.
  • Hijnen WAM, Beerendonk EF, Medema GJ. Inactivation credit of UV radiation for viruses, bacteria and protozoan (oo)cysts in water: A review. Wat Res. 2006;40(1):3–22. doi:10.1016/j.watres.2005.10.030.
  • Li J, Blatchley ER. UV photodegradation of inorganic chloramines. Environ Sci Technol. 2009;43(1):60–65. doi:10.1021/es8016304.
  • Lopez A, Bozzi A, Mascolo G, et al. Kinetic investigation on UV and UV/H2O2 degradations of pharmaceutical intermediates in aqueous solution. J Photochem Photobiol, A. 2003;156(1–3):121–126. doi:10.1016/S1010-6030(02)00435-5.
  • Wu JT, Wu CH, Liu CY, et al. Photodegradation of sulfonamide antimicrobial compounds (sulfadiazine, sulfamethizole, sulfamethoxazole and sulfathiazole) in various UV/oxidant systems. Water Sci Tech. 2015;71(3):412–417. doi:10.2166/wst.2015.005.
  • Ngouyap Mouamfon MV, Li W, Lu S, et al. Photodegradation of sulphamethoxazole under UV-light irradiation at 254 nm. Environ Technol. 2010;31(5):489–494. doi:10.1080/09593330903514854.
  • Andreozzi R, Marotta R, Paxéus N. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere. 2003;50(10):1319–1330. doi:10.1016/S0045-6535(02)00769-5.
  • Zhou W, Moore DE. Photochemical decomposition of sulfamethoxazole. Int J Pharm. 1994;110(1):55–63. doi:10.1016/0378-5173(94)90375-1.
  • Boreen AL, Arnold WA, McNeill K. Photochemical fate of sulfa drugs in the aquatic environment: sulfa drugs containing five-membered heterocyclic groups. Environ Sci Technol. 2004;38(14):3933–3940. doi:10.1021/es0353053.
  • Kurup L. Evaluation of the adsorption capacity of alkali-treated waste materials for the adsorption of sulphamethoxazole. Water Sci Technol. 2012;65(9):1531–1539. doi:10.2166/wst.2012.017.
  • Keen OS, Thurman EM, Ferrer I, et al. Dimer formation during UV photolysis of diclofenac. Chemosphere. 2013;93(9):1948–1956. doi:10.1016/j.chemosphere.2013.06.079.
  • Nghiem LD, Espendiller C, Braun G. Influence of organic and colloidal fouling on the removal of sulphamethoxazole by nanofiltration membranes. Water Sci Technol. 2008;58(1):163–169. doi:10.2166/wst.2008.647.
  • Gonçalves AG, Órfão JJM, Pereira MFR. Catalytic ozonation of sulphamethoxazole in the presence of carbon materials: catalytic performance and reaction pathways. J Hazard Mater. 2012: 239–240.:167–174. doi:10.1016/j.jhazmat.2012.08.057.
  • Naraginti S, Li Y, Puma GL. Photocatalytic mineralization and degradation kinetics of sulphamethoxazole and reactive red 194 over silver-zirconium co-doped titanium dioxide: reaction mechanisms and phytotoxicity assessment. Ecotoxicol Environ Saf. 2018;159:301–309. doi:10.1016/j.ecoenv.2018.04.062.
  • Santos-Juanes L, Sánchez JLG, López JLC, et al. Dissolved oxygen concentration: A key parameter in monitoring the photo-Fenton process. Appl Catal, B. 2011;104(3–4):316–323. doi:10.1016/j.apcatb.2011.03.013.
  • Villota N, Coralli I, Lomas JM. Changes of dissolved oxygen in aqueous solutions of caffeine oxidized by photo-Fenton reagent. Environ Technol. 2021;42(4):609–617. doi:10.1080/09593330.2019.1639830.
  • Boutiti A, Zouaghi R, Bendjabeur SE, et al. Photodegradation of 1-hexyl-3-methylimidazolium by UV/H2O2 and UV/TiO2: influence of pH and chloride. J Photochem Photobiol, A. 2017;336:164–169. doi:10.1016/j.jphotochem.2016.12.030.
  • García-Montaño J. Combination of advanced oxidation processes and biological treatments for commercial reactive azo dyes removal. PhD Universitat Autònoma de Barcelona. 2007.
  • Liu Y, Zhu K, Su M, et al. Influence of solution pH on degradation of atrazine during UV and UV/H2O2 oxidation: kinetics, mechanism, and degradation pathways. RSC Adv. 2019;9(61):35847–35861. doi:10.1039/c9ra05747a.
  • Carrizales S. Single and ternary removal of sulfonamidas from water using activated carbon. PhD Universidad Autónoma de San Luis Potosí. 2020.
  • Wu SH, Chu HQ, Dong BZ, et al. Removal of sulfamethoxazole by nanofiltration membrane. J Zhejiang Univ Sci A. 2010;11:868–878. doi:10.1631/jzus.a0900606.
  • Qiang Z, Adams C. Potentiometric determination of acid dissociation constants (pKa) for human and veterinary antibiotics. Water Res. 2004;38(12):2874–2890. doi:10.1016/j.watres.2004.03.017.
  • Zhong J, Yang B, Gao FZ, et al. Performance and mechanism in degradation of typical antibiotics and antibiotic resistance genes by magnetic resin-mediated UV-Fenton process. Ecotoxicol Environ Saf. 2021;227:Article 112908. doi:10.1016/j.ecoenv.2021.112908..
  • Hu L, Flanders PM, Miller PL, et al. Oxidation of sulfamethoxazole and related antimicrobial agents by TiO2 photocatalysis. Water Res. 2007;41(12):2612–2626. doi:10.1016/j.watres.2007.02.026.
  • Xiong Q, Liu YS, Hu LH, et al. Co-metabolism of sulfamethoxazole by a freshwater microalga Chlorella pyrenoidosa. Water Res. 2020;175:Article 115656. doi:10.1016/j.watres.2020.115656.
  • Trovó AG, Nogueira RFP, Agüera A, et al. Degradation of sulfamethoxazole in water by solar photo-Fenton. chemical and toxicological evaluation. Water Res. 2009;43(16):3922–3931. doi:10.1016/j.watres.2009.04.006.
  • Kumar A, Sharma SK, Sharma G, et al. Silicate glass matrix@Cu2O/Cu2V2O7 p-n heterojunction for enhanced visible light photo-degradation of sulfamethoxazole: high charge separation and interfacial transfer. J Hazard Mater. 2021;402: Article 123790. doi:10.1016/j.jhazmat.2020.123790.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.